CXCR2 and diffuse large B-cell lymphoma: In diffuse large B-cell lymphoma (DLBCL), NETs recruited via the IL8-CXCR2 axis activate TLR9, increasing NF-κB and p38 pathways and promoting tumor proliferation and growth [73,74,75].